MIRA
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ: MIRA · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$1.05
+2.94% today
Updated 2026-04-30
Market cap
$42.86M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.35
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $22371.00 | $3.36M | $858074.00 | $4.93M | $2.92M |
| Cash & equivalents | $3491.00 | $2.81M | $350978.00 | $4.60M | $2.83M |
| Current assets | $3491.00 | $2.91M | $494405.00 | $4.86M | $2.89M |
| Total liabilities | $90364.00 | $1.09M | $1.45M | $558097.00 | $723349.00 |
| Current liabilities | $90364.00 | $1.09M | $1.37M | $558097.00 | $723349.00 |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $-67993.00 | $2.26M | $-596232.00 | $4.37M | $2.20M |
| Retained earnings | $-67993.00 | $-2.24M | $-9.30M | $-21.29M | $-29.14M |
| Accounts receivable | — | — | — | $11862.00 | — |
| Inventory | — | — | — | $-11862.00 | — |
| Goodwill | — | — | — | — | — |